Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

5 Figures That Show Tilray Is a Mess


Although earnings season never really ends, this has been a bigger week than most regarding earnings reports from top-tier cannabis stocks. Yesterday, the largest marijuana stock in the world, Canopy Growth, reported its first-quarter operating results, while on Wednesday, we heard from Charlotte's Web, the leader in hemp-derived cannabidiol (CBD) market share in the United States.

Yet it might be Tilray's (NASDAQ: TLRY) second-quarter operating results, released after the closing bell on Tuesday, Aug. 13, that's hogged all of Wall Street's attention. And for good reason.

At this time last year, Tilray became Wall Street's darling. In a two-month period between its mid-July initial public offering and mid-September, its share price would climb from a list price of $17 to as high as $300 on an intraday basis. It was 1999 all over again, and short-term traders couldn't get enough of it.

Continue reading


Source Fool.com

Like: 0
Share

Comments